Pembrolizumab binding action to the PD-1 Receptor
Pembrolizumab binds to the PD-1 receptor and prevents the cancer cell expressed PD-L1 from biding to PD-1 receptor and tricking the T-cell to go into deep sleep.
Recent Posts
Pembrolizumab binding action to the PD-1 Receptor
